These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 36441068)
21. Cribriform architecture prostatic adenocarcinoma in needle biopsies is a strong independent predictor for lymph node metastases in radical prostatectomy. Downes MR; Xu B; van der Kwast TH Eur J Cancer; 2021 May; 148():432-439. PubMed ID: 33077335 [TBL] [Abstract][Full Text] [Related]
22. The Influence of the Intraductal Carcinoma of the Prostate on the Short-Term Oncological Outcomes. Kalemci S; Kizilay F; Simsir A; Emre Ergun K; Kose T Arch Esp Urol; 2022 Jun; 75(5):405-409. PubMed ID: 35983810 [TBL] [Abstract][Full Text] [Related]
23. The influence of the presence of intraductal carcinoma of the prostate on the grade group system's prognostic performance. Kato M; Hirakawa A; Kobayashi Y; Yamamoto A; Ishida R; Sano T; Kimura T; Majima T; Ishida S; Funahashi Y; Sassa N; Fujita T; Matsukawa Y; Yamamoto T; Hattori R; Gotoh M; Tsuzuki T Prostate; 2019 Jul; 79(10):1065-1070. PubMed ID: 31025722 [TBL] [Abstract][Full Text] [Related]
24. Intraductal Carcinoma of the Prostate on Diagnostic Needle Biopsy Predicts Prostate Cancer Mortality: A Population-Based Study. Saeter T; Vlatkovic L; Waaler G; Servoll E; Nesland JM; Axcrona K; Axcrona U Prostate; 2017 Jun; 77(8):859-865. PubMed ID: 28240424 [TBL] [Abstract][Full Text] [Related]
25. Diagnostic Accuracy and Prognostic Value of Serial Prostate Multiparametric Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer. Chu CE; Cowan JE; Lonergan PE; Washington SL; Fasulo V; de la Calle CM; Shinohara K; Westphalen AC; Carroll PR Eur Urol Oncol; 2022 Oct; 5(5):537-543. PubMed ID: 33483265 [TBL] [Abstract][Full Text] [Related]
26. Atypical intraductal proliferation detected in prostate needle biopsy is a marker of unsampled intraductal carcinoma and other adverse pathological features: a prospective clinicopathological study of 62 cases with emphasis on pathological outcomes. Shah RB; Nguyen JK; Przybycin CG; Reynolds JP; Cox R; Myles J; Klein E; McKenney JK Histopathology; 2019 Sep; 75(3):346-353. PubMed ID: 31012493 [TBL] [Abstract][Full Text] [Related]
27. Diagnostic Accuracy of Prostate Biopsy for Detecting Cribriform Gleason Pattern 4 Carcinoma and Intraductal Carcinoma in Paired Radical Prostatectomy Specimens: Implications for Active Surveillance. Ericson KJ; Wu SS; Lundy SD; Thomas LJ; Klein EA; McKenney JK J Urol; 2020 Feb; 203(2):311-319. PubMed ID: 31483693 [TBL] [Abstract][Full Text] [Related]
28. Prevalence of adverse pathology features in grade group 2 prostatectomy specimens with syn- or metachronous metastatic disease. Ma C; Downes M; Jain R; Ientilucci M; Fleshner N; Perlis N; van der Kwast T Prostate; 2022 Feb; 82(3):345-351. PubMed ID: 34878188 [TBL] [Abstract][Full Text] [Related]
29. Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis. Risbridger GP; Taylor RA; Clouston D; Sliwinski A; Thorne H; Hunter S; Li J; Mitchell G; Murphy D; Frydenberg M; Pook D; Pedersen J; Toivanen R; Wang H; Papargiris M; Lawrence MG; Bolton DM Eur Urol; 2015 Mar; 67(3):496-503. PubMed ID: 25154392 [TBL] [Abstract][Full Text] [Related]
30. Addition of Cribriform and Intraductal Carcinoma Presence to Prostate Biopsy Reporting Strengthens Pretreatment Risk Stratification Using CAPRA and NCCN Tools. Downes MR; Liu KN; Yu Y; Lajkosz K; Kroon LJ; Hollemans E; Fleshner N; Finelli A; van Leenders GJLH; Iczkowski KA; van der Kwast TH Clin Genitourin Cancer; 2024 Feb; 22(1):47-55. PubMed ID: 37558528 [TBL] [Abstract][Full Text] [Related]
31. Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate: A Survey of Genitourinary Subspecialists. Gandhi JS; Smith SC; Paner GP; McKenney JK; Sekhri R; Osunkoya AO; Baras AS; DeMarzo AM; Cheville JC; Jimenez RE; Trpkov K; Colecchia M; Ro JY; Montironi R; Menon S; Hes O; Williamson SR; Hirsch MS; Netto GJ; Fine SW; Sirohi D; Kaushal S; Sangoi A; Robinson BD; Kweldam CF; Humphrey PA; Hansel DE; Schultz L; Magi-Galluzzi C; Przybycin CG; Shah RB; Mehra R; Kunju LP; Aron M; Kryvenko ON; Kench JG; Kuroda N; Tavora F; van der Kwast T; Grignon DJ; Epstein JI; Reuter VE; Amin MB Am J Surg Pathol; 2020 May; 44(5):673-680. PubMed ID: 31876580 [TBL] [Abstract][Full Text] [Related]
32. Distinction between intraductal carcinoma of the prostate (IDC-P), high-grade dysplasia (PIN), and invasive prostatic adenocarcinoma, using molecular markers of cancer progression. Dawkins HJ; Sellner LN; Turbett GR; Thompson CA; Redmond SL; McNeal JE; Cohen RJ Prostate; 2000 Sep; 44(4):265-70. PubMed ID: 10951489 [TBL] [Abstract][Full Text] [Related]
33. GBX2 Methylation Is a Novel Prognostic Biomarker and Improves Prediction of Biochemical Recurrence Among Patients with Prostate Cancer Negative for Intraductal Carcinoma and Cribriform Architecture. Jeyapala R; Savio AJ; Olkhov-Mitsel E; Kamdar S; Zhao F; Cuizon C; Liu RSC; Zlotta A; Fleshner N; van der Kwast T; Bapat B Eur Urol Oncol; 2019 May; 2(3):231-238. PubMed ID: 31200836 [TBL] [Abstract][Full Text] [Related]
34. Improved Prostate Cancer Biopsy Grading by Incorporation of Invasive Cribriform and Intraductal Carcinoma in the 2014 Grade Groups. van Leenders GJLH; Kweldam CF; Hollemans E; Kümmerlin IP; Nieboer D; Verhoef EI; Remmers S; Incrocci L; Bangma CH; van der Kwast TH; Roobol MJ Eur Urol; 2020 Feb; 77(2):191-198. PubMed ID: 31439369 [TBL] [Abstract][Full Text] [Related]
35. The impact of intraductal carcinoma of the prostate on the site and timing of recurrence and cancer-specific survival. Trinh VQ; Sirois J; Benzerdjeb N; Mansoori BK; Grosset AA; Albadine R; Latour M; Mes-Masson AM; Hovington H; Bergeron A; Ladouceur M; Fradet Y; Saad F; Trudel D Prostate; 2018 Jul; 78(10):697-706. PubMed ID: 29603326 [TBL] [Abstract][Full Text] [Related]
36. Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings. Robinson BD; Epstein JI J Urol; 2010 Oct; 184(4):1328-33. PubMed ID: 20723921 [TBL] [Abstract][Full Text] [Related]
37. Low PI-RADS assessment category excludes extraprostatic extension (≥pT3a) of prostate cancer: a histology-validated study including 301 operated patients. Alessi S; Pricolo P; Summers P; Femia M; Tagliabue E; Renne G; Bianchi R; Musi G; De Cobelli O; Jereczek-Fossa BA; Bellomi M; Petralia G Eur Radiol; 2019 Oct; 29(10):5478-5487. PubMed ID: 30887199 [TBL] [Abstract][Full Text] [Related]
38. Pathological features of Prostate Imaging Reporting and Data System (PI-RADS) 3 MRI lesions in biopsy and radical prostatectomy specimens. Rahota RG; Diamand R; Malavaud B; Fiard G; Descotes JL; Peltier A; Beauval JB; Roumeguère T; Roumiguié M; Albisinni S; Ploussard G BJU Int; 2022 May; 129(5):621-626. PubMed ID: 34358405 [TBL] [Abstract][Full Text] [Related]
39. Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patients. Seyrek N; Hollemans E; Osanto S; Pelger RCM; van der Poel HG; Bekers E; Bangma CH; Rietbergen J; Roobol MJ; Schoots IG; van Leenders GJLH Histopathology; 2022 Feb; 80(3):558-565. PubMed ID: 34706119 [TBL] [Abstract][Full Text] [Related]
40. Intraductal carcinoma of the prostate on needle biopsy: Histologic features and clinical significance. Guo CC; Epstein JI Mod Pathol; 2006 Dec; 19(12):1528-35. PubMed ID: 16980940 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]